PATENT CLAIM ANALYSIS

Application Number: 16124066
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["546", "296000"]

Abstract:
Provided herein is a crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione dihydrate. Pharmaceutical compositions comprising the crystalline 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione dihydrate are also disclosed.

Claim (Index 13):
The dihydrate of  claim 1  having an infrared spectrum corresponding to the representative infrared spectrum depicted in  FIG. 6 .

Metadata:
- Claim Count in Document: 10.0
- Percentile: 97.0
- Lexical Diversity: 1.42105
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15849285', '15849324', '16124057', '15849442', '16124013']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8357947658516393
- 35 USC 102 Novelty (BERT): 0.6361546011738806
- Combined Prediction Score: 0.8158307493838634
- Mean Citation Score: 551.331446
- Max Citation Score: 593.86163
- Similarity Product: 586.7381431478917

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test